170 related articles for article (PubMed ID: 27340881)
41. Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy.
Ste-Marie LG; Schwartz SL; Hossain A; Desaiah D; Gaich GA
J Bone Miner Res; 2006 Feb; 21(2):283-91. PubMed ID: 16418784
[TBL] [Abstract][Full Text] [Related]
42. Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy.
Upton CE; Daniels JP; Davies MC
Climacteric; 2021 Oct; 24(5):453-458. PubMed ID: 33928827
[TBL] [Abstract][Full Text] [Related]
43. Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover.
Crofton PM; Evans N; Bath LE; Warner P; Whitehead TJ; Critchley HO; Kelnar CJ; Wallace WH
Clin Endocrinol (Oxf); 2010 Dec; 73(6):707-14. PubMed ID: 20738314
[TBL] [Abstract][Full Text] [Related]
44. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
Gordon CM; Grace E; Emans SJ; Feldman HA; Goodman E; Becker KA; Rosen CJ; Gundberg CM; LeBoff MS
J Clin Endocrinol Metab; 2002 Nov; 87(11):4935-41. PubMed ID: 12414853
[TBL] [Abstract][Full Text] [Related]
45. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
[TBL] [Abstract][Full Text] [Related]
46. Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy.
Going S; Lohman T; Houtkooper L; Metcalfe L; Flint-Wagner H; Blew R; Stanford V; Cussler E; Martin J; Teixeira P; Harris M; Milliken L; Figueroa-Galvez A; Weber J
Osteoporos Int; 2003 Aug; 14(8):637-43. PubMed ID: 12844212
[TBL] [Abstract][Full Text] [Related]
47. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
48. Physical training and hormone replacement therapy reduce the decrease in bone mineral density in perimenopausal women: a pilot study.
Bergström I; Freyschuss B; Landgren BM
Osteoporos Int; 2005 Jul; 16(7):823-8. PubMed ID: 15536539
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of premature ovarian failure patients by bushen tiaojing recipe combined hormone replacement therapy: a clinical observation].
Xu BH; Li MQ; Luo YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1332-5. PubMed ID: 24432674
[TBL] [Abstract][Full Text] [Related]
50. Comparing estrogen-based hormonal contraceptives and hormone therapy on bone mineral density in women with premature ovarian insufficiency: a systematic review.
Fine A; Busza A; Allen LM; Kelly C; Wolfman W; Jacobson M; Lega IC
Menopause; 2022 Feb; 29(3):351-359. PubMed ID: 35213521
[TBL] [Abstract][Full Text] [Related]
51. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.
Ensrud KE; Barrett-Connor EL; Schwartz A; Santora AC; Bauer DC; Suryawanshi S; Feldstein A; Haskell WL; Hochberg MC; Torner JC; Lombardi A; Black DM;
J Bone Miner Res; 2004 Aug; 19(8):1259-69. PubMed ID: 15231012
[TBL] [Abstract][Full Text] [Related]
52. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
[TBL] [Abstract][Full Text] [Related]
53. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
[TBL] [Abstract][Full Text] [Related]
54. Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study.
Dambha-Miller H; Hinton W; Wilcox CR; Joy M; Feher M; de Lusignan S
Fam Pract; 2022 Nov; 39(6):1049-1055. PubMed ID: 35577349
[TBL] [Abstract][Full Text] [Related]
55. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
[TBL] [Abstract][Full Text] [Related]
56. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study.
Jensen LB; Vestergaard P; Hermann AP; Gram J; Eiken P; Abrahamsen B; Brot C; Kolthoff N; Sørensen OH; Beck-Nielsen H; Nielsen SP; Charles P; Mosekilde L
J Bone Miner Res; 2003 Feb; 18(2):333-42. PubMed ID: 12568411
[TBL] [Abstract][Full Text] [Related]
57. Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial.
Jamal SA; Hamilton CJ; Eastell R; Cummings SR
JAMA; 2011 Feb; 305(8):800-7. PubMed ID: 21343579
[TBL] [Abstract][Full Text] [Related]
58. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure.
Anasti JN; Kalantaridou SN; Kimzey LM; Defensor RA; Nelson LM
Obstet Gynecol; 1998 Jan; 91(1):12-5. PubMed ID: 9464713
[TBL] [Abstract][Full Text] [Related]
59. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
Legroux-Gerot I; Vignau J; Collier F; Cortet B
Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
[TBL] [Abstract][Full Text] [Related]
60. Long-term follow-up of bone density in women with primary ovarian insufficiency.
Benetti-Pinto CL; Ferreira VB; Yela DA
Menopause; 2015 Sep; 22(9):946-9. PubMed ID: 25756693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
